Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  phosphorus P32
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-15 of 15 for your search:
Start Over
Phase III Study of L-PAM vs P-32 and Persantine plus Aspirin vs Placebo for Thrombocytic Myeloproliferative Disorders
Phase: Phase III
Type: Treatment
Status: Closed
Age: 30 and over
Sponsor:
Protocol IDs: PVSG-10
Phase III Chemotherapy with Fluoxymesterone, Oxymetholone, Testosterone and Splenectomy for Myeloproliferative Disorders and Refractory Anemia
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: PVSG-2
Phase III Melphalan Chemotherapy vs Intraperitoneal Radioactive Chromic Phosphate for Stage I Epithelial Ovarian Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-46, GOG-7862
Phase III Comparison of Venesection, Radiophosphorus, and Busulphan Chemotherapy in the Treatment of Polycythemia Vera (Summary Last Modified 07/93)
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 35
Sponsor:
Protocol IDs: MRC-LEUK-PRV, EU-92019, UICC-73057, UKM-MRC-PT-7357
Phase III Randomized Comparison of Intraperitoneal 32-P vs Combination Chemotherapy with CDDP/CTX as Adjuvant Therapy Following Complete Resection of Ovarian Carcinoma with Pelvic Extension or of Unfavorable Histology
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: GOG-95, MAYO-876102, NCCTG-876102, NCI-87-C-12, SWOG-9047, NCI-T87-0051N, T87-0051
Phase III Randomized Evaluation of Adjuvant Intraperitoneal 32-P Following Negative Second-Look Laparotomy in Patients with Stage III Epithelial Ovarian Carcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-0093, NCCTG-896151
Phase III Chemotherapy with CLB/PRED and CTX/ARA-C/PRED vs Total Body Radiotherapy for Chronic Lymphocytic Leukemia
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-3476
Phase I/II Study of Intratumoral Infusion of Colloidal 32-P Followed by Conventional Chemoradiotherapy for Unresectable Pancreatic Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CH/UMC-9210, NCI-V94-0454
Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BIOSP 202, NCT00247260
Phlebotomy plus P-32 vs Phlebotomy plus Antiaggregating Therapy for Polycythemia Vera
Phase: No phase specified
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor:
Protocol IDs: PVSG-5
Start Over